Commit Biologics appoints Mikkel Wandahl Pedersen as Chief Scientific Officer

Highly experienced leader with demonstrated track record of antibody-based drug discovery and pipeline advancementStrengthens Commit's leadership team after emerging from stealth with €16m seed financing Dr Pedersen will spearhead research and development of Commit's BiCETM technology as the Company moves towards drug candidate (DC) nominationView original content:https://www.prnewswire.co.uk/news-releases/commit-biologics-appoints-mikkel-wandahl-pedersen-as-chief-scientific-officer-302275405.html